The cerebellum in drug craving

被引:48
|
作者
Moreno-Rius, Josep [1 ]
Miquel, Marta [1 ]
机构
[1] Univ Jaume 1, Psychobiol, Castellon De La Plana, Spain
关键词
Craving; Cerebellum; Memory; Cue reactivity; Prediction; Expectations; STATE FUNCTIONAL CONNECTIVITY; POSITRON-EMISSION-TOMOGRAPHY; BRAIN ACTIVATION; CONDITIONED PREFERENCE; ANTERIOR CINGULATE; PREFRONTAL CORTEX; CEREBRAL-CORTEX; SMOKING CUES; ALCOHOL CUES; COCAINE CUES;
D O I
10.1016/j.drugalcdep.2016.12.028
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Craving has been considered one of the core features of addiction. It can be defined as the urge or conscious desire to use a drug elicited by the drug itself, drug-associated cues or stressors. Craving plays a major role in relapse, even after prolonged periods of abstinence, as well as in the maintenance of drug seeking in non-abstinent addicts. The circuitry of craving includes medial parts of the prefrontal cortex, ventral striatal zones, ventral tegmental area, ventral pallidum, and limbic regions. Interestingly, the cerebellum shows reciprocal loops with many of these areas. The cerebellum has been linked traditionally to motor functions but increasing evidence indicates that this part of the brain is also involved in functions related to cognition, prediction, learning, and memory. Moreover, the functional neuroimaging studies that have addressed the study of craving in humans repeatedly demonstrate cerebellar activation when craving is elicited by the presentation of drug-related cues. However, the role of cerebellar activity in these craving episodes remains unknown. Therefore, the main goal of this review is to provide a brief update on craving studies and the traditional neural basis of this phenomenon, and then discuss and propose a hypothesis for the function of the cerebellum in craving episodes. (C) 2017 Elsevier B.V. All rights reserved.
引用
下载
收藏
页码:151 / 158
页数:8
相关论文
共 50 条
  • [41] Clinical and laboratory assessment of the subjective experience of drug craving
    Rosenberg, Harold
    CLINICAL PSYCHOLOGY REVIEW, 2009, 29 (06) : 519 - 534
  • [42] Association Between Psychiatric Symptoms and Craving in Drug Withdrawal
    Wang, Mu
    Chen, Yanyan
    Li, Huazhi
    Zhang, Xiaoyu
    Xu, Yubing
    Ding, Zeng-Hui
    Ma, Zuchang
    Sun, Yining
    INTERNATIONAL JOURNAL OF MENTAL HEALTH AND ADDICTION, 2023, 21 (05) : 3174 - 3184
  • [44] Craving espresso: the dialetics in classifying caffeine as an abuse drug
    Max Kenedy Felix dos Santos
    Elaine C. Gavioli
    Lorena Santa Rosa
    Vanessa de Paula Soares-Rachetti
    Bruno Lobão-Soares
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2018, 391 : 1301 - 1318
  • [45] Association Between Psychiatric Symptoms and Craving in Drug Withdrawal
    Mu Wang
    Yanyan Chen
    Huazhi Li
    Xiaoyu Zhang
    Yubing Xu
    Zeng-Hui Ding
    Zuchang Ma
    Yining Sun
    International Journal of Mental Health and Addiction, 2023, 21 : 3174 - 3184
  • [46] Dual Pathology: Craving and Drug Abuse in Patients On Paliperidone
    Fernandez Mayo, L.
    Bano Rodrigo, D.
    Barbero Garcia, E.
    EUROPEAN PSYCHIATRY, 2015, 30
  • [47] Preventing incubation of drug craving to treat drug relapse: from bench to bedside
    Liu, Xiaoxing
    Yuan, Kai
    Lu, Tangsheng
    Lin, Xiao
    Zheng, Wei
    Xue, Yanxue
    Shi, Jie
    Lu, Lin
    Han, Ying
    MOLECULAR PSYCHIATRY, 2023, 28 (04) : 1415 - 1429
  • [48] Exacerbated Craving in the Presence of Stress and Drug Cues in Drug-Dependent Patients
    Preston, Kenzie L.
    Kowalczyk, William J.
    Phillips, Karran A.
    Jobes, Michelle L.
    Vahabzadeh, Massoud
    Lin, Jia-Ling
    Mezghanni, Mustapha
    Epstein, David H.
    NEUROPSYCHOPHARMACOLOGY, 2018, 43 (04) : 859 - 867
  • [49] Preventing incubation of drug craving to treat drug relapse: from bench to bedside
    Xiaoxing Liu
    Kai Yuan
    Tangsheng Lu
    Xiao Lin
    Wei Zheng
    Yanxue Xue
    Jie Shi
    Lin Lu
    Ying Han
    Molecular Psychiatry, 2023, 28 : 1415 - 1429
  • [50] RESEARCH INTO DRUG CRAVING YIELDS PROMISING THERAPIES FOR ADDICTION
    TAYLOR, G
    CLINICAL PHARMACY, 1989, 8 (12): : 824 - 827